GENESIS: a French National Resource to Study the Missing Heritability of Breast Cancer

Background: Less than 20% of familial breast cancer patients who undergo genetic testing for BRCA1 and BRCA2 carry a pathogenic mutation in one of these two genes. The GENESIS (GENE SISter) study was designed to identify new breast cancer susceptibility genes in women attending cancer genetics clinics and with no BRCA1/2 mutation.

Methods: The study involved the French national network of family cancer clinics. It was based on enrichment in genetic factors of the recruited population through case selection relying on familial criteria, but also on the consideration of environmental factors and endophenotypes like mammary density or tumor characteristics to assess potential genetic heterogeneity. One of the initial aims of GENESIS was to recruit affected sibpairs. Siblings were eligible when index cases and at least one affected sister were diagnosed with infiltrating mammary or ductal adenocarcinoma, with no BRCA1/2 mutation. In addition, unrelated controls and unaffected sisters were recruited. The enrolment of patients, their relatives and their controls, the collection of the clinical, epidemiological, familial and biological data were centralized by a coordinating center.

Results: Inclusion of participants started in February 2007 and ended in December 2013. A total of 1721 index cases, 826 affected sisters, 599 unaffected sisters and 1419 controls were included. 98% of participants completed the epidemiological questionnaire, 97% provided a blood sample, and 76% were able to provide mammograms. Index cases were on average 59 years old at inclusion, were born in 1950, and were 49.7 years of age at breast cancer diagnosis. The mean age at diagnosis of affected sisters was slightly higher (51.4 years). The representativeness of the control group was verified.

Conclusions: The size of the study, the availability of biological specimens and the clinical data collection together with the detailed and complete epidemiological questionnaire make this a unique national resource for investigation of the missing heritability of breast cancer, by taking into account environmental and life style factors and stratifying data on endophenotypes to decrease genetic heterogeneity.

Citing Articles

Breast tumors from ATM pathogenic variant carriers display a specific genome-wide DNA methylation profile.

Viart N, Renault A, Eon-Marchais S, Jiao Y, Fuhrmann L, El Houdigui S Breast Cancer Res. 2025; 27(1):36.

PMID: 40069712 PMC: 11899765. DOI: 10.1186/s13058-025-01988-w.

Safety of the Breast Cancer Adjuvant Radiotherapy in Ataxia-Telangiectasia Mutated Variant Carriers.

Bensenane R, Beddok A, Lesueur F, Fourquet A, Warcoin M, Le Mentec M Cancers (Basel). 2024; 16(7).

PMID: 38611095 PMC: 11010818. DOI: 10.3390/cancers16071417.

Identifying Genetic Variants and Metabolites Associated with Rapid Estimated Glomerular Filtration Rate Decline in Korea Based on Genome-Metabolomic Integrative Analysis.

Lee S, Han M, Moon S, Kim K, An W, Ryu H Metabolites. 2022; 12(11).

PMID: 36422279 PMC: 9695695. DOI: 10.3390/metabo12111139.

Genetics of Immune Dysregulation and Cancer Predisposition: Two Sides of the Same Coin.

Matza Porges S, Shamriz O Clin Exp Immunol. 2022; 210(2):114-127.

PMID: 36165533 PMC: 9750831. DOI: 10.1093/cei/uxac089.

Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.

Caputo S, Golmard L, Leone M, Damiola F, Guillaud-Bataille M, Revillion F Am J Hum Genet. 2021; 108(10):1907-1923.

PMID: 34597585 PMC: 8546044. DOI: 10.1016/j.ajhg.2021.09.003.

References

Siddiq A, Couch F, Chen G, Lindstrom S, Eccles D, Millikan R . A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet. 2012; 21(24):5373-84. PMC: 3510753. DOI: 10.1093/hmg/dds381. View

Antoniou A, Kuchenbaecker K, Soucy P, Beesley J, Chen X, McGuffog L . Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Res. 2012; 14(1):R33. PMC: 3496151. DOI: 10.1186/bcr3121. View

Ghoussaini M, Fletcher O, Michailidou K, Turnbull C, Schmidt M, Dicks E . Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet. 2012; 44(3):312-8. PMC: 3653403. DOI: 10.1038/ng.1049. View

Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M . Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet. 2010; 42(6):504-7. PMC: 3632836. DOI: 10.1038/ng.586. View

Thomas G, Jacobs K, Kraft P, Yeager M, Wacholder S, Cox D . A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet. 2009; 41(5):579-84. PMC: 2928646. DOI: 10.1038/ng.353. View

Ahmed S, Thomas G, Ghoussaini M, Healey C, Humphreys M, Platte R . Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet. 2009; 41(5):585-90. PMC: 2748125. DOI: 10.1038/ng.354. View

Zheng W, Long J, Gao Y, Li C, Zheng Y, Xiang Y . Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet. 2009; 41(3):324-8. PMC: 2754845. DOI: 10.1038/ng.318. View

Stacey S, Manolescu A, Sulem P, Thorlacius S, Gudjonsson S, Jonsson G . Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet. 2008; 40(6):703-6. DOI: 10.1038/ng.131. View

Easton D, Pooley K, Dunning A, Pharoah P, Thompson D, Ballinger D . Genome-wide association study identifies novel breast cancer susceptibility loci. Nature. 2007; 447(7148):1087-93. PMC: 2714974. DOI: 10.1038/nature05887. View

10.

Stacey S, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson S . Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet. 2007; 39(7):865-9. DOI: 10.1038/ng2064. View

11.

Hunter D, Kraft P, Jacobs K, Cox D, Yeager M, Hankinson S . A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet. 2007; 39(7):870-4. PMC: 3493132. DOI: 10.1038/ng2075. View

12.

Antoniou A, Easton D . Models of genetic susceptibility to breast cancer. Oncogene. 2006; 25(43):5898-905. DOI: 10.1038/sj.onc.1209879. View

13.

Damiola F, Schultz I, Barjhoux L, Sornin V, Dondon M, Eon-Marchais S . Mutation analysis of PALB2 gene in French breast cancer families. Breast Cancer Res Treat. 2015; 154(3):463-71. DOI: 10.1007/s10549-015-3625-7. View

14.

Blein S, Barjhoux L, Damiola F, Dondon M, Eon-Marchais S, Marcou M . Targeted Sequencing of the Mitochondrial Genome of Women at High Risk of Breast Cancer without Detectable Mutations in BRCA1/2. PLoS One. 2015; 10(9):e0136192. PMC: 4583250. DOI: 10.1371/journal.pone.0136192. View

15.

Peterlongo P, Catucci I, Colombo M, Caleca L, Mucaki E, Bogliolo M . FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor. Hum Mol Genet. 2015; 24(18):5345-55. PMC: 4550823. DOI: 10.1093/hmg/ddv251. View

16.

Southey M, Park D, Nguyen-Dumont T, Campbell I, Thompson E, Trainer A . COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration. Breast Cancer Res. 2013; 15(3):402. PMC: 3706918. DOI: 10.1186/bcr3434. View

17.

Melchor L, Benitez J . The complex genetic landscape of familial breast cancer. Hum Genet. 2013; 132(8):845-63. DOI: 10.1007/s00439-013-1299-y. View

18.

Couch F, Wang X, McGuffog L, Lee A, Olswold C, Kuchenbaecker K . Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet. 2013; 9(3):e1003212. PMC: 3609646. DOI: 10.1371/journal.pgen.1003212. View

19.

Gaudet M, Kuchenbaecker K, Vijai J, Klein R, Kirchhoff T, McGuffog L . Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet. 2013; 9(3):e1003173. PMC: 3609647. DOI: 10.1371/journal.pgen.1003173. View

20.

Garcia-Closas M, Couch F, Lindstrom S, Michailidou K, Schmidt M, Brook M . Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet. 2013; 45(4):392-8, 398e1-2. PMC: 3771695. DOI: 10.1038/ng.2561. View